A Discussion About a Hematology Career in Industry With Drs. Benjamin Kim and Mark Chao
Dr. Benjamin Kim and Dr. Mark Chao discuss what it's like for a hematologist holding an industry position.
Predicting Responses to Gemtuzumab Ozogamicin
Dr. Raetz looks at the use of gemtuzumab ozogamicin (CO) for the treatment of acute myeloid leukemia in adults and children.
Dr. Saad Usmani has a conversation with Drs. Laurie Sehn and Andrew Weyrich about what to expect at the 59th ASH Annual Meeting.
Dr. Ken Anderson provides an overview of ASH's research agenda including topics such as precision medicine and improving the state of care for VTE.
Take the image challenge to diagnose a 65-year-old man with one week of recurrent fevers, chills and severe headaches.
November/December 2017 Volume 14, Issue 6
View all Features articles
View all Diffusion articles
Dr. Kenneth Anderson provides an overview of ASH's research agenda including topics such as precision medicine, the state of care for VTE, epigenetic mechanisms, and stem cell biology and regenerative medicine.
View all president's column articles
View all Ask the Hematologist articles
View all Op-Ed articles
View all Mini Review articles
ASH continues to increase its efforts to expand and enhance the Society’s reach. NIH funding, efforts to ensure patient access to drugs, and sickle cell disease were top priorities on ASH’s advocacy agenda in 2017.
ASH continues to invest in and explore the important actions needed to make a significant difference in sickle cell disease (SCD) access to care, research, and global issues. Learn about the major advocacy-related initiatives undertaken by ASH in 2017.
ASH was very vocal on Congress’s repeated attempts to repeal and replace the Affordable Care Act (ACA). ASH opposed the legislation introduced in the House and the Senate and sent numerous letters to Congress outlining priorities and expressing concerns.
In 2017, ASH commented on numerous rules and regulations proposed by the Centers for Medicare and Medicaid Services (CMS), which impact physician payment. ASH is actively involved in various advisory committees and also continues to engage with lawmakers on Capitol Hill.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology